% ID/cc |
percentage of injected dose per cubic centimeter of tissue |
% ID/g |
percentage of injected dose per gram of tissue |
225Ac |
Actinium-225 |
APP |
amyloid peptide precursor |
BBB |
blood–brain barrier |
BTB |
brain-tumor barrier |
CDR |
complementary-determining region |
CH1/CH2/CH3 |
constant domain 1/2/3 of heavy chain |
CNS |
central nervous system |
GFAP |
glial fibrillary acidic protein |
GFP |
green fluorescence protein |
HCAb |
heavy-chain antibody |
HER |
human epidermal growth factor receptor |
131I |
Iodine-131 |
ID |
injected dose |
IGF1R |
insulin-like growth factor 1 receptor |
IgG |
immunoglobulin G |
111In |
Indium-111 |
NMDAR |
N-Methyl-D-Aspartate receptor |
PDL1 |
program death-ligand 1 |
PET |
PET |
RMT |
receptor-mediated transcytosis |
sDAb |
single-domain antibody |
99mTc |
Technetium-99m |
TfR |
transferrin receptor |
VCAM1 |
vascular cell adhesion molecule 1 |
VCAMelid |
VHH against VCAM1 |
VEGF |
vascular endothelium growth factor |
VH |
variable domain of conventional antibodies heavy chain |
VL |
variable domain of conventional antibodies light chain |
VHH |
variable domain of heavy-chain antibodies |
VHHs |
plural of VHH |
VNAR |
variable new antigen receptor |
WT |
wild-type |
89Zr |
Zirconium 89 |